Journal article
TAMI-03. IDENTIFICATION OF NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS THROUGH IN VIVO FUNCTIONAL GENOMICS
Abstract
Abstract
Brain metastasis, the most common tumor of the central nervous system, occurs in 20-36% of primary cancers. In particular, 40% of patients with non-small cell lung cancer (NSCLC) develop brain metastases, with a dismal survival of approximately 4-11 weeks without treatment, and 16 months with treatment. This highlights a large unmet need to develop novel targeted therapies for the treatment of lung-to-brain metastases …
Authors
Aghaei N; Lam F; Venugopal C; Singh S
Journal
Neuro-Oncology, Vol. 22, No. Supplement_2, pp. ii213–ii213
Publisher
Oxford University Press (OUP)
Publication Date
November 9, 2020
DOI
10.1093/neuonc/noaa215.892
ISSN
1522-8517